Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy M Frech

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Arthritis Care & Research|August 23, 2018
Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease SeverityJohn D Pauling, Elizabeth Reilly, Theresa Smith, et al.
JID Innovations : Skin Science From Molecules to Population Health|April 25, 2022
Expanding Personalized, Data-Driven Dermatology: Leveraging Digital Health Technology and Machine Learning to Improve Patient OutcomesShannon Wongvibulsin, Tracy M Frech, Mary-Margaret Chren, et al.
BMC Rheumatology|October 15, 2021
The frequency of Raynaud's phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration databaseTracy M Frech, Maureen A Murtaugh, Megan Amuan, et al.
Rheumatic Diseases Clinics of North America|April 7, 2023
Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?Tracy M Frech, Janet L Poole, Maureen Murtaugh, et al.
The Lancet. Rheumatology|January 24, 2024
Treatment efficacy in secondary Raynaud's phenomenonJohn D Pauling, Theresa Smith, Robyn T Domsic, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Patient participation in patient-reported outcome instrument development in systemic sclerosisJohn D Pauling, Tracy M Frech, Robyn T Domsic, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohortRebecca S Overbury, Maureen A Murtaugh, Tracy M Frech, et al.
Arthritis Care & Research|September 26, 2025
Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue-Related Raynaud Phenomenon in the United StatesTracy M Frech, Charles G Frech, W David Merryman, et al.
Arthritis Care & Research|April 24, 2014
Parental influence on systemic sclerosisTracy M Frech, Richard Pimentel, Geraldine Mineau, et al.
Computers in Biology and Medicine|August 30, 2014
Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisisDoug Redd, Tracy M Frech, Maureen A Murtaugh, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|August 23, 2018
Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease SeverityJohn D Pauling, Elizabeth Reilly, Theresa Smith, et al.
JID Innovations : Skin Science From Molecules to Population Health|April 25, 2022
Expanding Personalized, Data-Driven Dermatology: Leveraging Digital Health Technology and Machine Learning to Improve Patient OutcomesShannon Wongvibulsin, Tracy M Frech, Mary-Margaret Chren, et al.
BMC Rheumatology|October 15, 2021
The frequency of Raynaud's phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration databaseTracy M Frech, Maureen A Murtaugh, Megan Amuan, et al.
Rheumatic Diseases Clinics of North America|April 7, 2023
Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?Tracy M Frech, Janet L Poole, Maureen Murtaugh, et al.
The Lancet. Rheumatology|January 24, 2024
Treatment efficacy in secondary Raynaud's phenomenonJohn D Pauling, Theresa Smith, Robyn T Domsic, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Patient participation in patient-reported outcome instrument development in systemic sclerosisJohn D Pauling, Tracy M Frech, Robyn T Domsic, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohortRebecca S Overbury, Maureen A Murtaugh, Tracy M Frech, et al.
Arthritis Care & Research|September 26, 2025
Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue-Related Raynaud Phenomenon in the United StatesTracy M Frech, Charles G Frech, W David Merryman, et al.
Arthritis Care & Research|April 24, 2014
Parental influence on systemic sclerosisTracy M Frech, Richard Pimentel, Geraldine Mineau, et al.
Computers in Biology and Medicine|August 30, 2014
Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisisDoug Redd, Tracy M Frech, Maureen A Murtaugh, et al.
Pageof 11